Bausch Health Companies Inc.: Cataract trials

The registry lists 57 Cataract studies with Bausch Health Companies Inc. as lead sponsor. 1 are open to participants now and 33 have results posted.

Phase 1 1Phase 2 3Phase 3 19Phase 4 11No phase 23(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• IC-8 Apthera IOL New Enrollment Post Approval StudyRecruitingNCT06060041
• Clinical Evaluation of the Performance of the enVista® Aspire™ (EA) LensTerminatedNCT06479148Not applicableResults posted
• Clinical Study to Evaluate the Safety and Performance of the enVista® One-Piece Hydrophobic Acrylic Trifocal Intraocular Lens in Subjects Undergoing Cataract ExtractionCompletedNCT04224155Not applicableResults posted
• A Study of B + L Ophthalmic Viscosurgical Device (OVD) CVisc50CompletedNCT04192630Not applicableResults posted
• Clinical Evaluation of a Small Aperture Extended Depth of Focus Intraocular LensCompletedNCT03633695Not applicableResults posted
• Evaluate the Safety and Effectiveness of the enVista® One-Piece Hydrophobic Acrylic Trifocal Intraocular LensCompletedNCT03603600Not applicableResults posted
• Bausch & Lomb Ophthalmic Viscosurgical Device (OVD) Dispersive (DVisc40)CompletedNCT03511638Not applicableResults posted
• LE Gel for the Treatment of Ocular Inflammation and Pain Following Cataract SurgeryCompletedNCT02786901Phase 3Results posted
• Loteprednol Etabonate Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract SurgeryCompletedNCT02208297Phase 3Results posted
• EYEFILL® C. -US Viscoelastic Clinical InvestigationCompletedNCT02024711Not applicableResults posted
• Loteprednol Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract SurgeryCompletedNCT01996839Phase 3Results posted
• Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract SurgeryCompletedNCT01591655Phase 3Results posted
• Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract SurgeryCompletedNCT01591161Phase 3Results posted
• Loteprednol vs Prednisolone for the Treatment of Intraocular Inflammation Following Cataract Surgery in Children.CompletedNCT01475643Phase 3Results posted
• Efficacy of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract SurgeryCompletedNCT01367249Phase 3Results posted
• Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation Following Cataract SurgeryTerminatedNCT01298752Phase 3Results posted
• Co-Axial Micro-Incision Versus Co-Axial Small Incision Cataract Surgery Using the Stellaris Enhancement SystemCompletedNCT01261975Phase 4Results posted
• Accommodation Measurements After Bilateral Implantation of an Aspheric Accommodating Lens and Monofocal Aspheric LensesTerminatedNCT01241279Phase 4Results posted
• Mapracorat Ophthalmic Suspension for the Treatment of Ocular Inflammation Following Cataract SurgeryCompletedNCT01230125Phase 3Results posted
• One-Piece Hydrophobic Acrylic Intraocular Lens in Subjects Undergoing Cataract ExtractionCompletedNCT01230060Phase 3Results posted
• Three Intraocular Lenses Designed to Improve Distance, Intermediate and Near Vision Following Lens ExtractionCompletedNCT01225952Phase 4Results posted
• Toric Intraocular Lens Following Cataract SurgeryCompletedNCT01140477Not applicableResults posted
• Evaluation of 3 Intraocular Lenses Following Lens ExtractionCompletedNCT01122576Phase 4Results posted
• Evaluation of Loteprednol Etabonate Versus Vehicle for the Treatment of Inflammation and Pain Following Cataract SurgeryCompletedNCT01060072Phase 3Results posted
• Evaluation of BOL-303242-X Versus Vehicle for the Treatment of Inflammation Following Cataract SurgeryCompletedNCT00905450Phase 2Results posted
• Study of T-PRED(TM) Compared to Pred Forte(R) IICompletedNCT00854061Phase 3Results posted
• Assessment of the Concentrations of Besifloxacin, Moxifloxacin, or Gatifloxacin in the Aqueous Humor of SubjectsCompletedNCT00824070Phase 1Results posted
• Clinical Evaluation of a New Aspheric Intraocular Lens.CompletedNCT00786565Phase 4Results posted
• Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract SurgeryCompletedNCT00704418Phase 3Results posted
• Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract SurgeryCompletedNCT00703781Phase 3Results posted
• Study of T-PRED(TM) Compared to Pred Forte(R)CompletedNCT00699803Phase 2Results posted
• Loteprednol Etabonate in an Ophthalmic Base vs Vehicle for the Treatment of Inflammation Following Cataract SurgeryCompletedNCT00699153Phase 3Results posted
• Loteprednol Etabonate Ophthalmic Ointment vs. Vehicle in the Treatment of Inflammation Following Cataract SurgeryCompletedNCT00645671Phase 3Results posted
• Efficacy and Safety of Bromfenac Ophthalmic SolutionCompletedNCT00585975Phase 2Results posted
• A Post-Market Clinical Follow-Up on Safety and Performance of the Ophthalmic Viscoelastic Devices Eyefill SC and Eyefill MBCompletedNCT06767917Not applicable
• A Study to Evaluate Real World Outcomes of the enVista® Aspire (EA) and Aspire Toric (ETA) Intraocular Lens in Subjects Undergoing Cataract ExtractionCompletedNCT06594185Not applicable
• A Study to Evaluate the enVista® Aspire (EA) Intraocular Lens in Subjects Undergoing Cataract ExtractionCompletedNCT06333028
• Study to Evaluate the Safety and Effectiveness of the enVista® Beyond (EY) EDF Intraocular Lens in Subjects Undergoing Cataract ExtractionCompletedNCT06333015Not applicable
• Post-approval Follow-up Study of the IC-8 Apthera Intraocular Lens (IOL)CompletedNCT05758883
• Clinical Investigation of a Small Aperture Extended Depth of Focus Intraocular Lens in Patients With Complex CorneasCompletedNCT05574270Not applicable
• Evaluation of Visual Outcomes in Patients With Complex Corneas Implanted With the IC-8 IOLCompletedNCT05377515
• IOL Implantation After KAMRA Inlay RemovalCompletedNCT03320473Not applicable
• Evaluation of Long-Term Clinical Acceptability and Satisfaction With the IC-8 Intraocular LensCompletedNCT03314766
• Post Approval Study to Evaluate the Trulign™ Toric Posterior Chamber IOLCompletedNCT02394379
• Long-term (3 Months) Safety of Femtosecond-laser Assisted Cataract SurgeryCompletedNCT02023437Phase 4
• Addressing of Efficacy and Safety of Femtosecond-laser Assisted Versus Manual Lens Fragmentation ProcedureCompletedNCT01971177Phase 4
• A Single Centre Study to Analyze Cataract Surgery Following Femtosecond Laser-Assisted and Manual Cataract SurgeryCompletedNCT01769313Phase 4
• A Study to Address Precision and Refractive Predictability of Femtosecond Laser-assisted Astigmatic Keratotomy Following the Cataract SurgeryCompletedNCT01752218Not applicable
• Prospective Evaluation of Circularity and Diameter of Femtosecond Laser Versus Manual Anterior Capsulotomy in Singapore National Eye CentreCompletedNCT01693211Not applicable
• Evaluation of Clinical Outcomes Following Implantation of a Sub-2mm Hydrophilic MICS Intraocular LensCompletedNCT01615861Not applicable
• A Single Centre Study to Compare the Efficacy and Safety of Femtosecond Laser-Assisted Versus Manual Cataract SurgeryCompletedNCT01373853Phase 3
• Indomethacin Eyedrops Compared With Ketorolac Eyedrops for Ocular Inflammation Following Cataract SurgeryCompletedNCT00904904Phase 4
• Evaluation of the Safety & Effectiveness of the Bausch & Lomb AKREOS® TL Intraocular LensCompletedNCT00838045Phase 4
• Safety and Effectiveness of the Akreos Toric Intraocular Lens.CompletedNCT00825513Phase 4
• Evaluation of the Safety and Effectiveness of the Akreos MI Five-0 Intraocular Lens.TerminatedNCT00804726Not applicable
• Safety/Efficacy of Bromfenac Ophthalmic Solution for Ocular Inflammation and Pain Associated With Cataract SurgeryCompletedNCT00333918Phase 3
• Safety and Efficacy Study of Topical Bromfenac Versus Placebo to Treat Ocular Inflammation After Cataract SurgeryCompletedNCT00198445Phase 3